About Us
Nasasbiotech is a biotechnology company that develops novel clinical solutions in liquid biopsy to improve the diagnosis, prognosis and treatment of cancer.
Solutions
Nasasbiotech’s solutions are based on oncologists’ needs and follow a novel and disruptive approach.
Biomedicine
Biomedicine developments of the Translational Medical Oncology Laboratory of the Health Research Institute of Santiago de Compostela (IDIS).
Research
Study of circulating tumour cells, their role in the formation of metastasis, their use as tools of diagnosis and prognosis, and the development of systems for their control and capture.
Our Origin
Spin off
Nasasbiotech is a spin off from a biomedicine research project developed at the Translational Medical Oncology Laboratory of the Health Research Institute of Santiago de Compostela (IDIS).
Challenge
Its aim is to reach clinical practice and overcome the current main challenge in oncology: the process of metastasis, which is responsible for 90% of cancer-related deaths.
Strategies
Focused on the process of metastasis and specially on CTCs, as they are intermediaries and responsible for the formation of metastasis.
Tools
The philosophy of this Laboratory’s research projects is to provide useful tools to solve oncologists’ main medical needs.
Our prototype
The company has successfully developed a prototype of a cell capture medical device with the financial support of SERGAS through the PRIS programme (Programme for Pre-Commercial Development of Health Research Results) and Fundación Barrié, through its Science Fund.
OUR DEVELOPMENTS
